Evidence supporting the use of: DHA (Docosahexaenoic Acid)
For the health condition: Macular Degeneration

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Docosahexaenoic acid (DHA) is an omega-3 fatty acid present in high concentrations in the retina, particularly in the photoreceptor cells. Its biological role in maintaining retinal structure and function has led to interest in its potential for supporting or treating age-related macular degeneration (AMD). Several observational studies have suggested that higher dietary intake of DHA and other omega-3s is associated with a lower risk of developing AMD. For example, the Age-Related Eye Disease Study (AREDS) and AREDS2 trials evaluated the effects of omega-3 supplementation but did not find a significant benefit for progression to advanced AMD. However, some smaller randomized controlled trials and cohort studies have indicated that DHA may help reduce inflammation and oxidative stress in retinal tissues, mechanisms implicated in AMD pathogenesis.

Overall, while there is a clear biological rationale and some epidemiological support, large-scale clinical trials have not consistently demonstrated a significant clinical benefit for DHA supplementation in preventing or treating AMD. As such, DHA is included in some eye health supplements, but its use is better described as having modest scientific support rather than being fully validated. The current consensus among experts is that DHA may contribute to retinal health as part of a balanced diet, but it should not be relied upon as a primary treatment for AMD.

More about DHA (Docosahexaenoic Acid)
More about Macular Degeneration

Products containing DHA (Docosahexaenoic Acid)

We currently have no products on Vitabase that contain this ingredient.